Source: FIERCE MEDICAL DEVICES

Graphene Frontiers: New paradigms in diagnostics: graphene and a single drop of blood

Philadelphia's Graphene Frontiers is developing a hand-held, point-of-care diagnostic device that can detect heart attack biomarkers from a drop of blood within minutes, thanks to the use of the company's namesake material.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Bruce Willner's photo - CEO of Graphene Frontiers

CEO

Bruce Willner

CEO Approval Rating

90/100

Read more